Marchisio M A, Dubini M, Serra G, Mennini T, Manara L
Br J Ind Med. 1976 Nov;33(4):269-71. doi: 10.1136/oem.33.4.269.
Urinary and faecal excretion of radioactivity after either an intravenous or oral (1 mg/kg) dose of 35S-labelled Tobias acid (2-naphthylamino, 1-sulphonic acid), a dyestuff intermediate structurally similar to the powerful carcinogen 2-naphthylamine, was studied in rats. The Tobias acid was eliminated from the body within 24 hours of administration, almost exclusively through the urine. TLC-chromatography of faecal extracts and urine did not disclose the presence of excreted products other than unchanged Tobias acid and the search for inorganic 35SO4 in the urine by BaCl2 precipitation was negative. There was significant absorption from the gastrointestinal tract, but neither cleavage of the sulphonic group nor other biotransformation by the intestinal flora was apparent under the test condition. There was no evidence that the sulphonic group of Tobias acid is cleaved in the body to a significant extent to give 2-naphthylamine. This information should help in the evaluation of the occupational hazard potential of Tobias acid.
在大鼠中研究了静脉注射或口服(1毫克/千克)35S标记的托拜厄斯酸(2-萘胺-1-磺酸)后放射性物质的尿排泄和粪排泄情况。托拜厄斯酸是一种染料中间体,其结构与强力致癌物2-萘胺相似。给药后24小时内,托拜厄斯酸几乎完全通过尿液从体内排出。粪便提取物和尿液的薄层色谱分析未发现除未变化的托拜厄斯酸之外的排泄产物,并且通过氯化钡沉淀法在尿液中寻找无机35SO4的结果为阴性。胃肠道有显著吸收,但在测试条件下,磺酸基团既没有裂解,肠道菌群也没有进行其他生物转化。没有证据表明托拜厄斯酸的磺酸基团在体内会大量裂解生成2-萘胺。这些信息应有助于评估托拜厄斯酸的职业危害潜力。